Filtrer par catégorie
  • Tous
  • Congress
  • Blog
  • Congrès
  • Ressource Scientifique
  • Webinaire
  • Poster
  • Publication scientifique
  • Communiqué de Presse
  • Couverture presse
  • Actualités
Filtrer par catégorie
Circle Oncodesign Services
Scientific paper - Ressources
Poster
01/01/2018

EFMC-ISMC 2018 XXV – EFMC International Symposium on Medicinal Chemistry

Lire la suite
Scientific paper - Ressources
Poster
01/01/2018

Bio IT Congress – OncoSNIPE, Al initiative designed to identify and characterize patients resistant or non responder to cancer treatments

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
18/12/2017

Promising clinical results for innovative mutated anti-EGFR radiotracer in patients with non-small cell lung cancer

Lire la suite
Financial Press Release | Oncodesign
17/12/2017

US – Oncodesign has entered into a services agreement with Eisai to develop a new personalized medicine program in earlier line metastatic breast cancer treatment

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
05/12/2017

Oncodesign reports positive results for its MNK1/2 program

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
15/11/2017

Oncodesign announces positive results opening the way for the ALK1 program to advance to the lead optimization phase

Lire la suite
Scientific publications | Oncodesign Services
Publication scientifique
01/11/2017

PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models

PDX-MI: Minimal Information for Patient-Derived Tumor Xenograft Models

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
18/10/2017

OncoSNIPE® artificial intelligence project officially launched

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
05/10/2017

Oncodesign launches its new website

Lire la suite
Scientific paper - Ressources
Poster
01/10/2017

Synergistic Anticancer Activity of Eribulin Plus Palbociclib in Patient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer

Synergistic Anticancer Activity of Eribulin Plus Palbociclib inPatient-Derived Xenograft (PDX) Models of ER+/Her2- Human Breast Cancer

Lire la suite
Scientific paper - Ressources
Poster
01/10/2017

Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy

Identification by systematic in situ hybridization screen on medaka embryos of new genes as targets for anti-cancer therapy

Lire la suite
Financial Press Release | Oncodesign
Communiqué de Presse
31/08/2017

Oncodesign announces the acquisition of Bertin Pharma’s pharmaceutical and biotech services businesses

Lire la suite